Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
5.48 -0.06 / -1.08%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.48 0.00 / 0.00%
Volume: 1.9K

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Progenics Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +82.48% increase from the last price of 5.48.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Progenics Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.00%
Growthannually -980.00%


Growthquarterly 556.05%
Growthannually -80.88%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account